Related Experiment Video

Updated: Jan 19, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

37.7K

The pandemic influenza vaccine challenge

Marie Paule Kieny, Keiji Fukuda

    Vaccine
    |February 21, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Optimization of a Quantitative Micro-neutralization Assay
    10:09

    Optimization of a Quantitative Micro-neutralization Assay

    Published on: December 14, 2016

    21.9K
    Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
    10:39

    Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

    Published on: June 25, 2015

    13.1K

    Related Experiment Videos

    Last Updated: Jan 19, 2026

    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    37.7K
    Optimization of a Quantitative Micro-neutralization Assay
    10:09

    Optimization of a Quantitative Micro-neutralization Assay

    Published on: December 14, 2016

    21.9K
    Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
    10:39

    Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

    Published on: June 25, 2015

    13.1K

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    51.3K
    Overview
    51.3K

    Articles linked to this work by shared authors, journal, and citation graph.

    Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination.

    iScience·2024

    Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's story.

    BMJ global health·2023

    Longitudinal monitoring reveals the emergence and spread of blaGES-5-harboring carbapenem-resistant Klebsiella quasipneumoniae in a Hong Kong hospital wastewater discharge line.

    The Science of the total environment·2023

    Antimicrobial Resistance Policy Protagonists and Processes-A Qualitative Study of Policy Advocacy and Implementation.

    Antibiotics (Basel, Switzerland)·2022

    Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.

    Health policy and planning·2022

    Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).

    Vaccine·2021

    Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021-2022.

    Vaccine·2026

    Human papillomavirus (HPV) Vaccination programmes across European countries: time-harmonized coverage among adolescent females, socioeconomic predictors, and impact on public interest.

    Vaccine·2026

    Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant.

    Vaccine·2026

    Diphtheria in Switzerland, 1877-2022: long-term epidemiology and the impact of mid-20th-century vaccination programs.

    Vaccine·2026

    Cell culture-derived vaccine for rabbit haemorrhagic disease virus 2.

    Vaccine·2026

    AS04-adjuvanted semisynthetic glycoconjugate vaccine against Pseudomonas aeruginosa.

    Vaccine·2026

    Factors impacting protective immunity conferred by vaccination with adeno-associated virus-like particles displaying human papillomavirus L2 residues 17-36.

    Journal of virology·2026

    Time-Dependent Changes in YKL-40 and Inflammatory Markers in Experimental Acute Mesenteric Ischemia.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

    Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains.

    mBio·2026

    Antibody-mediated SARS-CoV-2 entry and conformational regulation.

    Microbiology spectrum·2026

    Microbial and functional shifts between flare and remission in a single-center cohort of children with inflammatory bowel disease.

    World journal of clinical pediatrics·2026

    Molecular innate immune programs of tumor-associated macrophages in immune checkpoint blockade resistance: a staged framework from suppressive circuitry to translational bottlenecks.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us